2XW-49407-04591 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-20
Dose 1 — Pfizer-BioNTech
2021-03-13
Dose 2 — Pfizer-BioNTech
2021-03-16
Registered in v-safe
2021-03-16
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-03-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-03-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Nausea

Adult check-in
2021-03-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-20
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-03-27
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-05
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-10
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-17
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-04-24
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-12
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-09-11
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-20
Dose 3 — Pfizer-BioNTech
2022-03-15
Survey response — 12 months, dose 2
MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Pregnancy

MedDRA releases: 2024-11 · check-in free text available
2022-03-15
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-03-16
Call 1 — Left Voicemail
2022-05-21
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-11-22
Survey response — 12 months, dose 3
MedDRA: Benign neoplasm — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Benign tumor

MedDRA releases: 2024-11 · check-in free text available
2022-11-22
Report sent to call center — 12 months, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-11-23
Call 2 — Left Voicemail
2022-11-23
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-20	Pfizer-BioNTech
2	2021-03-13	Pfizer-BioNTech
3	2021-11-20	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-03-15	Unsuccessful
2022-11-22	Unsuccessful

Free text

Release 11 — 12 months, dose 2

2022-03-15

Symptoms: Pregnancy

Release 12 — 12 months, dose 3

2022-11-22

Symptoms: Benign tumor

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Benign neoplasm	·	·	✓
SD	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release